GeneCentric Therapeutics

GeneCentric is a precision oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression. With a foundation built on over a decade of research, GeneCentric’s innovations are embodied in the GenomicsNext platform, a multimodal liquid biopsy solution that simultaneously detects DNA alterations and inferred gene expression from a single blood sample. GeneCentric is expanding the boundaries of what circulating tumor DNA can reveal, advancing the next generation of precision medicine.